Why esmo Is Trending Today?

Caris Life Sciences will present six collaborative studies at the European Society for Medical Oncology (ESMO) 2025 conference. TransCode Therapeutics has shared preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO. iOnctura has debuted clinical data on cambritaxestat (IOA-28G) in patients with pancreatic cancer at the ESMO conference. Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) presented preclinical data on GNTbm-TKI, a novel multi-tyrosine kinase inhibitor with potent immune activation, at the 2025 ESMO Annual Meeting.

- **Lula**, in a speech at Rome, stated that fiscal adjustment programs are not an end in themselves. - AdvanCell will present promising clinical trial results of ADVC001, a novel lead-212-based PSMA-targeted alpha therapy for prostate cancer, at the **ESMO 2025** congress. - **Lupin** has announced it will present phase 1 data on LNP3693, a STING agonist, at the **ESMO Congress 2025**. - **Incyte** will present data on its bispecific TGFβR2×PD-1 antibody and KRAS G12D inhibitor at the **ESMO 2025** congress. - Despite releasing a new album, **Taylor Swift** may not be eligible for a Grammy for the first time since she was 17. - Insolvency applications in Germany increased by 10.4% in September 2025 compared to the previous year, with a 13.4% increase in corporate insolvencies and a 12.9% increase in consumer insolvencies in July 2025 compared to July 2024. - The **ESMO** conference is approaching, and the Hong Kong-listed innovative drug ETF (520690) has declined by over 3.5%, with institutions noting that the trend of innovative drugs going global is long-term. - **Taiho Oncology** and **Cullinan Therapeutics** will present data on Zipalertinib in patients with NSCLC with EGFR mutations and active brain metastases at the **ESMO Congress 2025**. - **Desmond Bryant**, a former NFL player, has endorsed a Miami wellness startup that organizes hikes for executives before a $3,500 reset.

Despite various challenges, Jaguar I-Pace production ends this year, Suzano maintains production, and attacks on buses in São Paulo persist despite police operations. In medical news, ESMO GI 2025 presents promising combinations for treating advanced liver and colorectal cancers.

At the ESMO GI 2025 conference, several studies presented promising results for various cancer treatments, including the use of magrolimab and nivolumab with mFOLFIRINOX for unresectable pancreatic cancer, durvalumab with FLOT for resectable gastric cancer, zongertinib for HER2-altered advanced gastrointestinal cancers, and atezolizumab and bevacizumab with TACE for unresectable hepatocellular carcinoma. Additionally, teodora će pobesneti, Diogo Jota, and a former CAC member were in the news, while motorcycle sales increased by 8.1% in June 2025 compared to the same month in 2024, and the PSD rejected the PS's suggestion to vote on immigration proposals this Friday.